Skin irritation is a common occupational hazard for employees engaged in the manufacture, transport, and use of industrial chemicals. The most common method used to evaluate dermal irritation and/or corrosion has typically been in vivo tests using rabbits (Draize method). Several in vitro test methods have been developed, with Corrositex being the first to gain approval by a regulatory agency (U.S. Department of Transportation). The purpose of this study was to compare the results of in vitro (Corrositex) assays of dermal irritation/corrosion to in vivo test data for several industrial chemical formulations and to determine the predictability and usefulness of the Corrositex assay for these types of products. Twenty-four (24) formulations were qualified, categorized, and evaluated using the Corrositex method and the results compared to available animal data for each of the formulations. The Corrositex assay accurately predicted a corrosive end point in 8 (57.1%) of the 14 formulations identified as corrosive by the in vivo evaluations. Corrositex accurately predicted a noncorrosive end point for 1 (10%) of 10 formulations determined to be noncorrosive in animal studies. The Corrositex assay overpredicted the packing group for 12 (50%) of the 24 formulations, and underpredicted the packing group for 7 (29.2%) of the 24 formulations. Compared to the in vivo results, Corrositex correctly classified as corrosive or noncorrosive 37.5% of the formulations tested. A concordance of 20.8% for the packing group assignments of the evaluated formulations was calculated. The Corrositex assay did not accurately predict a corrosive end point or packing group assignment for all of the formulations used in this study. Manufacturers should assess the relevance of this method to their products prior to relying on it for compliance with hazardous material and worker safety regulations.
The most common occupational hazard for employees engaged in the manufacture, use, and transport of industrial chemicals is dermal irritation and corrosion. Laws in place to mitigate this hazard include the Hazardous Materials Transportation Act (HMTA) and the Occupational Safety and Health Act. The regulations stemming from these laws have relied on dermal irritation/corrosion tests on animals to predict, categorize, and label dermal hazards. The most common is the Draize (rabbit) test (Draize, Woodard, and Calvery 1944) , which can cause great discomfort and pain to the animals being tested. As a result of increased sensitivity to laboratory animal welfare, several in vitro test methods have been developed. The development of alternatives and replacement of in vivo tests was initiated by public concern and pressure on the cosmetics and personal care industries (Cooper 1996) . Industrial chemicals, however, generally have a greater irritation and corrosion potential than cosmetic ingredients and thus, present a greater degree of risk to both humans and laboratory animals.
The United Nations (U.N.) established internationally recognized recommendations for the labeling of chemicals during transport (United Nations Economic Commission for Europe 2002). In the United States, the Department of Transportation (U.S. DOT) administers a labeling classification system based on the U.N. recommendations under the HMTA (49 CFR 172). The U.S. labeling classification system consists of categories, called packing groups, which are based on the severity of dermal corrosion observed in the animal tests. The U.S. DOT has granted exemptions and allowed the use of the Corrositex assay as an alternative to standard animal testing to determine skin corrosivity of selected chemical types (U.S. DOT 1995) . The exemptions included the following chemical classes: acids (inorganic and organic), inorganic and organic acid derivatives (anhydrides, haloacids, salts, etc.) , acyl halides, alkylamines and polyalkylamines, bases (inorganic and organic), chlorosilanes, metal halides, and oxyhalides. The Corrositex assay was modified prior to the 1995 renewal of the DOT exemption to extend the range of compatibility, and eliminates the necessity of confirmatory animal testing for substances determined by the Corrositex assay to be noncorrosive (InVitro International 1995) .
The initial exemption, and subsequent renewals, relied on validation studies performed on a variety of chemical products. Many of the substances used in the DOT validation study were listed by product use as opposed to chemical class, because the composition of the test substance was claimed proprietary. Limitations with the Corrositex model have been identified with metal salts, pure organic solvents, selected industrial cleaner formulations, petrochemicals, agrochemicals, and volatile compounds and formulations, and aqueous compounds with pH values ranging between 5 and 8.5 (InVitro International 1992a; InVitro International 1995) . These types of products, formulations, and compounds were not included in this study. The fact that the components of the Corrositex assay may be chemically incompatible with certain classes of chemicals is a limitation of this in vitro model. Consideration also should be given to possible interactions among chemical components of industrial formulations, and how these formulations may interact with the test assay itself.
Corrositex is an in vitro test method designed to predict corrosion caused by dermal chemical exposure and to permit assignment of packing group classification for corrosive materials. There are advantages for companies to use in vitro technologies for predicting human responses. Societal animal welfare considerations are reflected in regulatory policy and agency endorsement. Agencies that accept Corrositex data include the U.S. DOT, U.S. Environmental Protection Agency, National Institute of Environmental Health Sciences (NIEHS), Food and Drug Administration (FDA), Occupational Safety and Health Administration (OSHA), and Consumer Product Safety Commission (CPSC) (InVitro International 1995; U.S. DOT 1995; U.S. Federal Register 1995) . In vitro assays are generally less expensive than animal tests. The cost of a Corrositex assay is approximately $1100 per test substance, compared to a standard animal test that typically costs up to $2000 per test substance. The Corrositex assay is also faster. Traditional animal studies require a minimum of 3 days, in addition to shipment and acclimation times for the animals. A Corrositex assay can be conducted in 1 day, often in only a few hours. With proper validation, this reduced turn around time allows the Corrositex assay data to be incorporated into a corporate research screening program, which results in better hazard communication at an earlier stage of product development, thus providing a higher level of protection to employees working with new products.
Interest in and development of in vitro test methods will continue to increase as regulatory agencies look for more accurate, cost-effective, and humane testing procedures. However, agencies and industries must be assured that the in vitro assay will accurately predict in vivo results to correctly communicate dermal hazards. The objective of this study was to validate the use of the Corrositex assay to predict skin corrosion caused by dermal exposure to industrial chemical formulations used in the pulp and paper, coatings, and water treatment industries. The formulations used in this study were selected on the basis of available animal data for comparison. Corrositex assays were performed with selected formulations and the results were compared to available in vivo data.
MATERIALS AND METHODS
Product formulations evaluated for this study were selected from the pulp and paper, coatings, and industrial water treatment industries. Twenty-four (24) formulations were selected for this study, based, in part, on the availability of in vivo dermal irritation/corrosion data. All selected formulations were qualified and categorized according to Corrositex protocols (InVitro International 1995) . Table 1 lists the selected formulations, and includes the chemical class and pH. Corrositex assays were performed on each of the test substances, and the results were compared to available in vivo results.
Corrositex Method
The Corrositex assay utilizes the target biomacromolecular approach to predict dermal irritation and corrosion (Gordon, Harvell, and Maibach 1994a ). The test system consists of glass vials, which contain the chemical detection system (CDS) covered by a biobarrier membrane disc. The CDS is an ambercolored liquid composed of water and two pH indicator dyes (one basic indicator, phenyl red, and one acidic indicator, methyl orange). The biobarrier consists of a cellulose membrane covered with a collagen gel. An aliquot (500 µl) of the test material is placed on the biobarrier membrane, and the time to an observed change in either the color or consistency in the CDS is determined. A change in the CDS indicates that the test substance has either diffused through or degraded the biobarrier membrane, and changed the pH of the CDS, resulting in the observed color change. The time it takes for this to occur is referred to as "breakthrough time." Breakthrough times are inversely proportional to the severity of corrosion. Packing group assignment is based on the breakthrough time and determined using the U.N. Packing Group Assignment Table in the Corrositex instructions ( Table 2) .
Classification of Test Substances
Prior to conducting the tests, all formulations were qualified, categorized, and classified (InVitro International 1995) . Qualification involves a direct addition of the test substance to the CDS to verify that the test substance will cause a change in the CDS and is therefore compatible with the Corrositex assay. Categorization determines the appropriate cut-off times for correct classification of the formulation. This is done by adding 150 µl of the test substance to two buffer solutions to categorize the test formulation as acidic (pH 0 to 7) or basic (pH 7 to 14). A color change occurs if the test substance changes either of the two buffer solutions by greater than 1.0 pH units (Gordon et al. 1994b ). The resulting color change was compared to the corresponding color charts on the Corrositex testing protocol poster (InVitro International 1995) . If there was not a color change in either of the buffer solutions during the categorization step, two drops of a "confirm" reagent were added to each of the tubes, and the resulting color was recorded. Conversely, if both of the buffer tubes changed color due to an intensely colored test substance, the pH of a 10% aqueous solution of the test substance was mea-sured to determine which of the buffer tubes to use (pH 0-7 = tube A; pH 7-14 = tube B). The test substance was then added to the appropriate tube, shaken, and the pH of the buffer solution was measured to determine the appropriate category.
To classify the formulations, 500 µl of the selected formulation were placed on each of four replicate biobarrier membranes and chemical detection system assemblies. The start time for each replicate was recorded, and the vials observed until a change in the CDS occurred. The breakthrough time was recorded for each of the four replicates. The average time was compared to the packing group assignment table, and the classification (as corrosive or noncorrosive, and packing group assignment) determined and recorded.
Quality Assurance/Quality Control
The date of preparation and use of the biobarriers were recorded for each batch. The plastic biobarrier containers were wrapped with paraffin film and stored at 2 • C to 8 • C. All biobarriers were stored under refrigeration for at least 2 hours prior to the test, and were used within 7 days of preparation, as per manufacturer's instructions (InVitro International 1995) .
A blank (color) control, a positive control, and a negative control were included in each assay. The blank control remained uncapped during the test to ensure CDS was not contaminated. A 70% nitric acid in de-ionized water solution was used as the positive control. The breakthrough times for the positive controls were all within the acceptable time range of 0.5 to 2.0 minutes. A 6% (volume/volume) aqueous solution of propionic acid was used as the negative control. The breakthrough times for all negative controls were greater than the acceptable time of 60 minutes (InVitro International 1995).
Draize Method
The in vivo or animal data for the 24 formulations used in this study were generated in industrial primary skin irritation studies conducted by independent contract laboratories (Buckman Laboratories International, Inc. 1989 -1996 . No additional animal studies were conducted to generate in vivo data for the comparisons used in this study.
The in vivo, or Draize, method has been the method of choice for determining the irritation/corrosion potential of chemicals. This evaluation involves the application of the test substance to three different sites on the shaved backs of New Zealand white rabbits (usually six). The test substance is applied to a 1 × 1-inch gauze bandage and secured to the application site with tape. All test sites are then occluded with plastic wrap and secured. Each animal serves as its own control. At 3 minutes, the first test site patch is removed, the test substance is washed off using warm water, and the site evaluated for irritation/corrosion. At 60 minutes, the second test site patch is removed, washed, and observations of both sites 1 and 2 are made. Finally, at 4 hours, the third test site patch is removed and observations are made of all three test sites. Observations of all three sites (Draize, Woodard, and Calvery 1944) . Corrosion is defined as irreversible full-thickness necrosis of the skin after a specified period of time (U.S. Code of Federal Regulations 1995, 49 CFR 173.136 and 173.137 ). If the irritation is determined to be too severe (i.e., corrosion occurs immediately) the animal is immediately euthanized. All animals are euthanized at the termination of the study.
Statistical Analyses
There are several published methods used to compare in vivo and in vitro results in studies where binary data are generated (Cooper, Saracci, and Cole 1979; Gordon, Harvell, and Maibach 1994a; Holzhutter et al. 1996) . Cooper, Saracci, and Cole (1979) described such a comparison for in vitro carcinogenicity screening tests and the following parameters were calculated: sensitivity, specificity, predictive value, prevalence, false-positive proportion, and false-negative proportion. In this study, sensitivity is the proportion of corrosive test substances that were correctly identified as corrosive by the Corrositex test. Specificity is the proportion of noncorrosive substances that were correctly identified as noncorrosive by the Corrositex test. The predictive value is defined as the number of test formulations determined to be corrosive by both the in vivo and in vitro (Corrositex) tests, divided by the total number of formulations identified as corrosive by the Corrositex test. Prevalence is the number of corrosive test formulations, as identified by in vivo tests, divided by the total number of substances tested. The false-positive proportion is the number of noncorrosive test substances (as determined by in vivo tests) that were identified as corrosive by Corrositex divided by the total number of noncorrosive test substances (as identified by in vivo tests). The false-negative proportion is the number of corrosive test substances (as identified by in vivo tests) that were identified by Corrositex as noncorrosive divided by the total number of corrosive test substances (as identified by in vivo tests). The mathematical formulas defining these parameters are presented in Table 3 . Holzhutter et al. (1996) expanded on the above parameters to include a negative predictive value, or negative predictivity. This is the number of true noncorrosive substances divided by the total substances identified by Corrositex as being noncorrosive. This is opposite of the term, "predictive value," described by Cooper, Saracci, and Cole (1979) . Predictive value can therefore be thought of in terms of positive predictability. Holzhutter et al. also described overall accuracy for measuring in vitro test performance as the sum of the accurate in vitro responses divided by the total number of test substances (Table 3) .
Packing group concordance, overestimation, and underestimation were also evaluated according to methods published by Gordon, Harvell, and Maibach (1994a) . Concordance occurs when both the in vivo and in vitro data agree. Overestimation occurs when the in vitro assay predicts a higher packing group assignment than the in vivo data. Conversely, underestimation occurs when the in vitro data predicts a lower packing group assignment than the in vivo data.
RESULTS
Twenty-four formulations were tested using the Corrositex method (Table 1 ) and the results were compared to available in vivo data for each of the formulations (Table 4 ). All comparisons in this study are based on the assumption that the in vivo test results (the accepted standard) correctly classified the formulations as corrosive or noncorrosive, or into packing groups. The comparisons of the packing group assignments from in vitro (Corrositex) and in vivo assays are also presented in Table 4 . Table 5 summarizes the statistical parameters comparing corrosive and noncorrosive data from in vitro (Corrositex) and in vivo evaluations. The corrosive/noncorrosive and packing group concordance of in vivo and in vitro (Corrositex) results are summarized and presented in Table 6 . The prevalence of true corrosives among the test substances was 58.0%. The Corrositex assay accurately predicted a corrosive end point in 57.1% (8 of 14) of the formulations identified as corrosive by the in vivo evaluations. Corrositex accurately predicted a noncorrosive endpoint for 10% (1 of 10) of the formulations determined to be noncorrosive in animal studies. Corrositex overpredicted the packing group for 50% (12 of 24) of the formulations, and underpredicted the packing group for 29.2% (7 of 24) of the formulations. These data result in a sensitivity of 57.1% and a specificity of 10.0%, with a positive predictive value of 47.0%, and a negative predictive value of 14.3%. The false-positive rate was 90.0% and the false-negative rate was 42.8%. The accuracy of the Corrositex assay was calculated to be 37.5%.
Packing group concordance between the Corrositex and in vivo results was also determined. The Corrositex assay accurately predicted the packing group assignment in 16.6% (4 of 24) of the formulations tested. The Corrositex assay overpredicted the packing group assignment in 50.0% (12 of 24) of the formulations tested, and underpredicted the packing group assignment in 29.2% (7 of 24) of the formulations tested.
The Corrositex results were also compared to the in vivo data among like chemical classes. For all water-based formulations of phosphonic acids (formulation code numbers or FCNs 1 to 6), Corrositex overpredicted a corrosive end point for all six formulations. The Corrositex method resulted in a packing group II (PG II) assignment for all six formulations, whereas the in vivo studies determined that all six formulations were noncorrosive. Corrositex accurately predicted a corrosive end point for 40.0% (2 of 5, FCNs 7 and 10) of the water-based dithiocarbamate formulations (FCNs 7 to 11), but overpredicted the packing group assignment for both. The in vitro assay overpre- dicted a corrosive end point for the remaining (3 of 5; FCNs 8, 9, and 11) formulations and assigned them to PG II. These formulations were determined to be noncorrosive by the in vivo studies. For all of the dithiocarbamate/dithioimidocarbonate formulations (FCNs 12 to 14) , the Corrositex assay accurately predicted both a corrosive end point and the packing group assignment. Corrositex accurately distinguished between a PG III assignment for FCN 12, and PG II assignments for FCNs 13 and 14. For FCNs 15 to 17 (all solvent-based formulations of 2-thiocyanomethylthio(benzothiazole)), the Corrositex assay predicted all three formulations to be noncorrosive, whereas the in vivo data showed them all to be PG III materials. This inconsistency was also observed with FCN 18, a water-based formulation of 2-thiocyanomethylthio(benzothiazole). Two solventbased formulations of 2-bromo-4 -hydroxyacetophenone were tested (FCNs 19 and 20) . For these two formulations, the Corrositex assay resulted in a noncorrosive classification, whereas both formulations were determined to be PG III materials by animal studies. The Corrositex assay accurately predicted a corrosive end point for FCN 21 (a water-based formulation of 3,5dimethyltetrahydro-1,3,5-2H-thiadiazine-2-thione); however, the assay overpredicted the packing group assignment with a PG II classification, whereas the animal data showed this formulation to be a PG III material. The Corrositex assay accurately predicted a noncorrosive end point for FCN 22, a water-based formulation of a quaternary ammonium compound. For FCN 23, a water-based formulation of an alkyl substituted amine, the Corrositex assay accurately predicted a corrosive end point, but underpredicted the packing group assignment. In this case, the animal study showed this material to have a PG I classification, whereas the Corrositex assay resulted in a PG II classification. Finally, the Corrositex assay accurately predicted both a corrosive end point and a packing group assignment of PG II for FCN 24, a water-based formulation containing sodium hydroxide.
DISCUSSION
Several validation studies have been performed on the Corrositex assay, and were used to support the applications for the DOT exemptions. A 1996 technical report, included in the Corrositex reference manual, presented the results of several analyses validating the assay. One study evaluated 83 chemicals listed on the DOT Corrosive Chemicals Table ( 49 CFR 172.101) and reported that the Corrositex assay correctly identified 91.6% (76 of 83) as corrosive, with a false-negative rate of 8.4% (7 of 83). There are corresponding in vivo data for 34 of these chemicals. The in vivo data identified only 70.6% (24 of 34) of the chemicals as corrosive, with a false-negative rate of 29.4% (10 of 34). Clearly the DOT List of Corrosive Chemicals (49 CFR 172.101) is based on chemical or formulation pH, not on actual in vivo irritation/corrosion evaluations. A comparison of the Corrositex results with the in vivo results available for these 34 chemicals was not conducted.
InVitro International (1992b) analyzed Corrositex data for 419 chemicals or formulations, 370 of those with corresponding in vivo data. A comparison, similar to that utilized in this study, of the in vitro (Corrositex) and in vivo results was conducted. The accuracy was reported to be 85.1% (315 of 370). Other descriptive parameters reported included sensitivity = 90.6% (144 of 159), specificity = 81.0% (171 of 211), false positive rate = 10.8% (40 of 370), and false negative rate = 4.0% (15 of 370). The data were separated by chemical classification and reanalyzed. The chemical classifications included inorganic and organic acids, inorganic and organic bases, inorganic and organic acids and bases, inorganic and organic acids, acid mixtures and acid derivatives, and alkylamines and polyamines. The analyses typically resulted in higher accuracy, sensitivity, and specificity, with lower false-positive and -negative rates.
In the 1992 application for exemption (49 CFR 173.136 and 173.136) submitted by In Vitro International, the results of six intra-and interlaboratory studies comparing in vitro (Corrositex) and in vivo tests were presented. The conclusions, based on these studies included (1) Corrositex correctly identified 97.7% of the chemicals evaluated as corrosive and noncorrosive;
(2) Corrositex assigned the correct packing group, or a safer group, for 95% of tested chemicals; (3) Corrositex underestimated only three test samples (3%) of 92 tested formulations; and (4) interlaboratory reproducibility ranges from 93% to 95%. Gordon, Harvell, and Maibach (1994a) conducted an accuracy study using Corrositex with surfactants and surfactantbased formulations. Of the 75 chemicals evaluated in this study, the Corrositex assay had an accuracy of 97.3%, and a packing group accuracy of 88%.
The accuracy of the Corrositex assay was only 37.5% in this study (Table 5 ). This descriptive parameter takes into account the number of correctly predicted corrosive and noncorrosive substances compared to the total number of test substances. The Corrositex assay, in this study, did not exhibit the high accuracy reported in existing studies (InVitro International 1995) . However, the number of different chemical classes evaluated in this study (10) is much smaller compared to previous studies (InVitro International 1992b; InVitro International 1995) , and could have biased the results. The sensitivity and specificity determined in this study (51.1% and 10.0%, respectively) were also much lower and the false-positive and -negative proportions much higher (90.0% and 42.8%, respectively) than those previously reported.
A predictive value (positive predictability) of 47% for determining a corrosive end point was calculated for the Corrositex assay in the present study (Table 5 ). The predictive value has been criticized as an indicator of true predictability, as it can be influenced by the specificity in studies where the prevalence of true positives selected for the test is less than 80% (Cooper, Saracci, and Cole 1979) . The specificity for the Corrositex assay in this study was 10%. This reflects the number of noncorrosive formulations (based on in vivo data) that were also shown to be noncorrosive by Corrositex. Therefore, the predictive value should be considered together with negative predictability (14.3%) to provide a better assessment of the predictability of the Corrositex assay, within the scope of this study.
In general, the parameters describing the predictive characteristics of the Corrositex assay (Tables 5 to 6) indicate that the in vitro results are not comparable to the in vivo results. The dissimilarity between the results and conclusions of this study and previous studies is difficult to explain. The tests were conducted according to manufacturer's specifications and the results were acceptable based on the (QA/QC) data. All the formulations evaluated in this study were qualified and categorized. This study evaluated industrial product formulations whereas a majority of the compounds evaluated in previous studies were ≥95% pure. It is possible that the formulation chemistry somehow effected the Corrositex response and therefore classification. It was expected that many of the formulations tested would be corrosive based on the low (<2) and high (>11) pH of the samples. However, several were determined to be not corrosive.
The Corrositex assay provided consistent results within each of the chemical classes evaluated. For example, for all of the water-based phosphonic acid formulations, the Corrositex assay predicted consistently that these formulations should be classified as PG II materials, whereas the animal data determined them not to be corrosive. This is not unexpected because of the dependence upon pH for the Corrositex assay. All of the phosphonic acid formulations had extreme pH values, on both the lower and upper ends of the pH scale (Table 1) .
The Corrositex assay also consistently predicted the classification of the 2-thiocyanomethylthio(benzothiazole) formulations. These formulations were determined to be noncorrosive by the Corrositex assay, whereas they were predicted to be PG III materials by animal studies. This could suggest that these formulations are actually borderline between being severely irritating to corrosive. It is also interesting to note that, with the 2-thiocyanomethylthio(benzothiazole) formulations, the formulation makeup appeared to have made no difference to either the Corrositex or the animal data. Three of the four of these formulations had the same concentration of 2-thiocyanomethylthio(benzothiazole). The one water-based formulation was determined to have the same result as the three solvent-based formulations, in both the in vitro and in vivo tests.
The quality of existing animal data is, and will always be, a potential limitation for any in vitro test method comparisons and validations. Existing animal data were used in this study because it would be considered unethical to conduct additional animal studies solely for the purpose of comparison to Corrositex (Balls and Clothier 1987) .
The Draize method has been used to predict skin irritation for approximately 50 years, and is considered the standard for skin irritation tests. This method also has limitations. The method is subjective, which can cause varied results depending on the observer. Corrosion can be considered the result of several different visually interpreted end points, including subcutaneous hemorrhaging, dermal pitting, and/or blistering of the skin. Variation in skin thickness and in the number of hair follicles per square centimeter of skin may contribute to inherent variability among test animals. Some individual animals are more difficult to handle and may not be patched as well as others. Differences in the degree of test site occlusion can also cause varying results among test animals (Battista and Rieger 1971) . All of these factors make interlaboratory reproducibility difficult with the Draize method.
Changes in the manufacturing process of a product or formulation can also be a limitation to the animal data. For example, formulation number 9 was the only formulation among the test substances with two different animal study results. This formulation was first tested in 1991 and a corrosive end point (PG III) was determined. The same formulation was tested again in 1996 and a noncorrosive end point was determined. Upon further investigation, it was learned that the manufacturing process by which the active ingredient was made changed between 1991 and 1996. Although the resulting formulation had not changed, the manufacturing process changed to reduce the pH. The formulation tested in 1991 was a product with pH 12 and the formulation tested in 1996 was a product with pH 9. In this case, it is known that the manufacturing process changed because the manufacturer retested the formulation. However, changes can frequently occur to the manufacturing process and the product may not be retested, probably due to the fact that the manufacturer may not consider the process change significant enough to warrant a new animal test. This can result in the comparison of an in vivo test conducted on one substance to an in vitro test conducted on a slightly different substance. Therefore, it is important to verify the actual substance or formulation tested.
From a human health and safety perspective, it better to be overpredictive regarding skin corrosion warnings than to be underpredictive. The Corrositex assay overpredicted a corrosive end point for 35.7% (9 of 24) of the formulations tested, and overpredicted the packing group classification for 50% (12 of 24) of the formulations tested (Tables 5 to 6 ). However, overpredicting corrosion hazards also increases the costs associated with the handling, packaging, and shipping of the products. A corrosive end point was underpredicted by the Corrositex assay in 25% (6 of 24) of the formulations tested, and the packing group classification was underpredicted for 29.2% (7 of 24) of the formulations tested. These results indicate that there is a significant risk in relying on in vitro results with these formulations because they did not accurately predict in vivo results, underestimated the true dermal hazard, and could result in inaccurate hazard communication. Scientifically, all discrepancies would be considered inaccuracies regardless of whether the test method was over-or underpredictive. Inaccuracies may result in increased risk and/or costs associated with producing, shipping, and using these products. It is important that the corrosive end point be accurately predicted.
The Corrositex assay did not adequately predict a corrosive end point or packing group assignment for the 24 formulations used in this study. The formulations tested were products typically used in industrial operations such as pulp and paper manufacturing, paint and coatings manufacturing, and industrial water treatment operations. The test substances selected for this study have not been included in any validation studies with the Corrositex assay. Similarly, the in vivo data used for comparison in this study has not been used in any validation study. This study was designed as a practical application of the Corrositex method. The method appears to have been inadequate for predicting the corrosive hazards of the test substances included in this study. The Corrositex assay should be questioned as to its usefulness prior to relying on it as a sole predictor of skin corrosion hazard. This assay could be valuable if incorporated into a screening program to possibly reduce the need for animal testing, especially in the case of strong corrosive materials. Companies should assess the relevance of this in vitro method for their products prior to relying on it for compliance with hazardous material and worker safety regulations.
